Neurizon Therapeutics Limited (ASX:NUZ)
0.1200
-0.0050 (-4.00%)
At close: Apr 24, 2025, 4:00 PM AEST
Neurizon Therapeutics Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
Cash & Equivalents | 10.11 | 9.71 | 2.71 | 2.42 | 3.02 | 2.88 | Upgrade
|
Short-Term Investments | - | 1.02 | 0.02 | 0 | 0 | 0 | Upgrade
|
Cash & Short-Term Investments | 10.11 | 10.73 | 2.72 | 2.42 | 3.02 | 2.88 | Upgrade
|
Cash Growth | 85.52% | 294.23% | 12.47% | -19.99% | 4.84% | 37.70% | Upgrade
|
Accounts Receivable | 0.07 | 0.02 | 0.15 | 0.19 | 0.24 | 0.3 | Upgrade
|
Receivables | 0.07 | 0.02 | 0.15 | 0.19 | 0.24 | 0.3 | Upgrade
|
Inventory | - | - | - | 1.04 | 1.01 | 0.86 | Upgrade
|
Prepaid Expenses | - | 0.25 | 0.09 | 0.06 | 0.06 | 0.02 | Upgrade
|
Other Current Assets | 5.35 | 0.13 | 0.07 | 0.02 | 0.02 | 0.01 | Upgrade
|
Total Current Assets | 15.53 | 11.12 | 3.02 | 3.73 | 4.36 | 4.07 | Upgrade
|
Property, Plant & Equipment | - | - | 0 | 3.24 | 3.45 | 3.57 | Upgrade
|
Other Intangible Assets | - | - | 3.11 | 3.11 | 3.14 | 3.11 | Upgrade
|
Total Assets | 15.53 | 11.12 | 6.13 | 10.08 | 10.95 | 10.75 | Upgrade
|
Accounts Payable | 3.54 | 0.83 | 0.93 | 0.6 | 0.56 | 0.56 | Upgrade
|
Accrued Expenses | 0.08 | 0.03 | 0.26 | 0.21 | 0.21 | 0.15 | Upgrade
|
Short-Term Debt | - | - | - | 0.21 | - | - | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | - | 0.04 | 0.18 | Upgrade
|
Current Portion of Leases | - | - | 0.16 | 0.14 | 0.11 | 0.18 | Upgrade
|
Other Current Liabilities | - | 0.04 | - | - | - | - | Upgrade
|
Total Current Liabilities | 3.62 | 0.9 | 1.35 | 1.17 | 0.91 | 1.06 | Upgrade
|
Long-Term Debt | - | - | - | - | - | 0.04 | Upgrade
|
Long-Term Leases | - | - | 0.89 | 1.04 | 1.13 | 1.08 | Upgrade
|
Total Liabilities | 3.62 | 0.9 | 2.24 | 2.23 | 2.07 | 2.22 | Upgrade
|
Common Stock | 78.8 | 69.94 | 57.63 | 55.34 | 55.33 | 53.77 | Upgrade
|
Retained Earnings | -68.66 | -64.13 | -56.46 | -50.25 | -48.54 | -47.2 | Upgrade
|
Comprehensive Income & Other | 1.77 | 4.42 | 2.72 | 2.75 | 2.09 | 1.96 | Upgrade
|
Shareholders' Equity | 11.91 | 10.23 | 3.89 | 7.84 | 8.88 | 8.53 | Upgrade
|
Total Liabilities & Equity | 15.53 | 11.12 | 6.13 | 10.08 | 10.95 | 10.75 | Upgrade
|
Total Debt | - | - | 1.05 | 1.39 | 1.28 | 1.47 | Upgrade
|
Net Cash (Debt) | 10.11 | 10.73 | 1.67 | 1.03 | 1.75 | 1.41 | Upgrade
|
Net Cash Growth | 85.52% | 541.45% | 61.66% | -40.75% | 23.61% | -20.19% | Upgrade
|
Net Cash Per Share | 0.02 | 0.03 | 0.01 | 0.00 | 0.01 | 0.00 | Upgrade
|
Filing Date Shares Outstanding | 492.31 | 486.22 | 348.77 | 316.91 | 316.73 | 315.85 | Upgrade
|
Total Common Shares Outstanding | 492.31 | 445.02 | 347.47 | 316.91 | 316.73 | 302.02 | Upgrade
|
Working Capital | 11.91 | 10.23 | 1.67 | 2.56 | 3.45 | 3.01 | Upgrade
|
Book Value Per Share | 0.02 | 0.02 | 0.01 | 0.02 | 0.03 | 0.03 | Upgrade
|
Tangible Book Value | 11.91 | 10.23 | 0.78 | 4.73 | 5.74 | 5.42 | Upgrade
|
Tangible Book Value Per Share | 0.02 | 0.02 | 0.00 | 0.01 | 0.02 | 0.02 | Upgrade
|
Machinery | - | - | - | 3.63 | 3.64 | 3.53 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.